|
| Press Releases |
|
 |
|
| Thursday, May 21, 2015 |
|
|
領航推出首隻在香港聯合交易所上市的標準普爾500指數ETF |
全球最大互惠基金公司1及以低成本投資見稱的領航集團 (「Vanguard」或「領航」) 今天推出領航標準普爾500指數ETF (股票代號：3140)，令領航在香港市場的ETF產品 增至五個。
more info >> |
|
|
Vanguard Launches the First S&P 500 Exchange-traded Fund Listed on the Hong Kong Stock Exchange |
Vanguard, the world's largest mutual fund company1 and a leader in low-cost investing, is launching the Vanguard S&P 500 Index ETF (stock code: 3140) today, bringing the number of Vanguard ETF offerings in the Hong Kong market to five.
more info >> |
|
| Friday, June 13, 2014 |
|
|
全球領先的基金經理領航(Vanguard)推出三項全新ETF |
全球最大互惠基金公司1及以低成本投資見稱的領航集團(「Vanguard」或「領航」) 擴展產品組合，於香港推出三項全新的交易所買賣基金(「ETF」)。
more info >> |
|
|
Leading Global Fund Manager Vanguard Launches Three New ETFs |
Vanguard, the world's largest mutual fund company1 and a leader in low-cost investing, is expanding its product offering with three new Hong Kong-domiciled exchange traded funds (ETFs).
more info >> |
|
| Wednesday, May 15, 2013 |
|
|
著名基金經理領航(Vanguard)推出香港註冊的亞洲（日本除外）股票ETF |
| 全球最大互惠基金公司及以低成本投資領先市場的領航集團（「領航」）推出首個香港註冊的交易所買賣基金(ETF)，有關基金將於今天開始在香港聯交所買賣。領航富時亞洲（日本除外）指數ETF為實物ETF，投資於11個亞洲國家的大型及中型市值股票，為投資者提供多元化的投資選擇。 more info >> |
|
|
Leading Fund Manager Vanguard Unveils Hong Kong-domiciled Asia ex Japan Equity ETF |
| The first Hong Kong-domiciled exchange traded fund (ETF) to be offered by The Vanguard Group, Inc. (Vanguard), the world's largest mutual fund company and a leader in low- cost investing, will commence trading on the Hong Kong Stock Exchange today. more info >> |
|
| Monday, May 6, 2013 |
|
|
全球最大規模投資管理公司之一領航(Vanguard)進軍香港零售市場 |
| 全球領先的互惠基金公司領航(Vanguard)今天宣佈，於香港開展中介業務，將其投資產品帶給亞洲地區的投資者。領航向以低投資成本、清晰的收費及多元化投資組合而聞名全球。 more info >> |
|
|
Vanguard, One of World's Largest Investment Management Companies, Enters Hong Kong Retail Market |
| Vanguard, the pioneering mutual fund company known around the world for setting the standard for low investment costs, clear fee disclosures and broadly diversified portfolios, today launched its intermediary business in Hong Kong to expand access to its products to investors throughout Asia. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Naoris Protocol Announces Upcoming TGE for $NAORIS
Jul 29, 2025 23:59: JST
|
|
|
Naoris Protocol Announces Upcoming TGE for $NAORIS
Jul 29, 2025 23:59 HKT/SGT
|
|
|
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Jul 29, 2025 23:39 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 29, 2025 23:13 HKT/SGT
|
|
|
GTJAI Achieved 'Carbon Neutrality' at Operational Level for the Third Consecutive Year
Jul 29, 2025 23:06 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Jul 29, 2025 20:00 JST
|
|
|
Wintermar Offshore (WINS:JK) Reports 1H2025 Results
Jul 29, 2025 18:56 HKT/SGT
|
|
|
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
|
|
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇樹衝刺IPO、機械人應用加速落地：首程控股雙輪驅動兌現紅利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
宇树冲刺IPO、机器人应用加速落地：首程控股双轮驱动兑现红利
Jul 29, 2025 11:30 HKT/SGT
|
|
|
國泰君安國際連續第三年實現營運層面「碳中和」
Jul 29, 2025 11:19 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 9:01 JST
|
|
|
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果
Jul 29, 2025 08:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
